...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery
【24h】

Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery

机译:七氟醚与异丙酚的随机比较减少围手术期心肌缺血,术后术后心术手术

获取原文
获取原文并翻译 | 示例

摘要

Background: Volatile anesthetics provide myocardial preconditioning in coronary surgery patients. We hypothesized that sevoflurane compared with propofol reduces the incidence of myocardial ischemia in patients undergoing major noncardiac surgery. Methods and Results: We enrolled 385 patients at cardiovascular risk in 3 centers. Patients were randomized to maintenance of anesthesia with sevoflurane or propofol. We recorded continuous ECG for 48 hours perioperatively, measured troponin T and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) on postoperative days 1 and 2, and evaluated postoperative delirium by the Confusion Assessment Method. At 6 and 12 months, we contacted patients by telephone to assess major adverse cardiac events. The primary end point was a composite of myocardial ischemia detected by continuous ECG and/or troponin elevation. Additional end points were postoperative NT-proBNP concentrations, major adverse cardiac events, and delirium. Patients and outcome assessors were blinded. We tested dichotomous end points by χ2 test and NT-proBNP by Mann-Whitney test on an intention-to-treat basis. Myocardial ischemia occurred in 75 patients (40.8%) in the sevoflurane and 81 (40.3%) in the propofol group (relative risk, 1.01; 95% confidence interval, 0.78-1.30). NT-proBNP release did not differ across allocation on postoperative day 1 or 2. Within 12 months, 14 patients (7.6%) suffered a major adverse cardiac event after sevoflurane and 17 (8.5%) after propofol (relative risk, 0.90; 95% confidence interval, 0.44-1.83). The incidence of delirium did not differ (11.4% versus 14.4%; P=0.379). Conclusions: Compared with propofol, sevoflurane did not reduce the incidence of myocardial ischemia in high-risk patients undergoing major noncardiac surgery. The sevoflurane and propofol groups did not differ in postoperative NT-proBNP release, major adverse cardiac events at 1 year, or delirium.
机译:背景:挥发性麻醉剂提供冠状动脉外科患者的心肌预处理。我们假设七氟醚与异丙酚相比减少了患有主要非心动手术的心肌缺血的发病率。方法和结果:我们在3个中心的心血管风险中注册了385名患者。患者随机与七氟烷或异丙酚的麻醉维持。我们在术后48小时内记录了48小时的48小时,术后第1天和第2天脑利钠肽(NT-PROPNP),并通过混淆评估方法评估术后谵妄。在6和12个月,我们通过电话联系了患者,以评估主要的不良心脏事件。主要终点是由连续的心电图和/或肌钙蛋白升高检测的心肌缺血的复合物。额外的终点是术后NT-ProPNP浓度,主要不良心脏事件和谵妄。患者和结果评估员是盲目的。通过曼 - 惠特尼试验,通过曼 - Whitney试验测试二分终点,以曼 - 惠特尼试验到治疗。在七氟醚中的75名患者(40.8%)中发生心肌缺血,在丙比罗基团中的81(40.3%)(相对风险,1.01; 95%置信区间,0.78-1.30)。术后第1天或2的分配没有不同的分配在12个月内,14名患者(7.6%)在七氟醚后患有主要的不利心脏事件,在异丙酚(相对风险,0.90; 95%)后,17(8.5%)置信区间,0.44-1.83)。谵妄的发病率没有区别(11.4%,与14.4%; P = 0.379)。结论:与异丙酚相比,七氟醚并未降低高危患者进行主要的非心动手术的心肌缺血发生率。七氟醚和异丙酚基团在术后NT-probnp释放,1年或谵妄的主要不良心脏事件没有不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号